HER3 expression is enhanced during progression of lung adenocarcinoma without EGFR mutation from stage 0 to IA1
ConclusionHER3 tends to be intensively expressed during the progression of lung adenocarcinoma without EGFR mutation from carcinoma in situ to invasive carcinoma.
Source: Thoracic Cancer - Category: Cancer & Oncology Authors: Toru Kumagai, Yasuhiko Tomita, Shin ‐ichi Nakatsuka, Madoka Kimura, Kei Kunimasa, Takako Inoue, Motohiro Tamiya, Kazumi Nishino, Yoshiyuki Susaki, Takashi Kusu, Toshiteru Tokunaga, Jiro Okami, Masahiko Higashiyama, Fumio Imamura Tags: ORIGINAL ARTICLE Source Type: research
More News: Adenocarcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | CT Scan | Genetics | HER2 | Lung Cancer